Predicting tumour radiosensitivity to deliver precision radiotherapy

JM Price, A Prabhakaran, CML West - Nature Reviews Clinical …, 2023 - nature.com
Owing to advances in radiotherapy, the physical properties of radiation can be optimized to
enable individualized treatment; however, optimization is rarely based on biological …

New paradigms and future challenges in radiation oncology: an update of biological targets and technology

SL Liauw, PP Connell, RR Weichselbaum - Science translational …, 2013 - science.org
Radiation oncology exploits the biological interaction of radiation within tissue to promote
tumor death while minimizing damage to surrounding normal tissue. The clinical delivery of …

[HTML][HTML] COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma

M Yang, X Wu, J Hu, Y Wang, Y Wang, L Zhang… - Journal of …, 2022 - Elsevier
Background & Aims Copper (Cu) is an essential trace element whose serum levels have
been reported to act as an effective indicator of the efficacy of radiotherapy. However, little is …

Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis

JG Scott, G Sedor, P Ellsworth, JA Scarborough… - The Lancet …, 2021 - thelancet.com
Background Despite advances in cancer genomics, radiotherapy is still prescribed on the
basis of an empirical one-size-fits-all paradigm. Previously, we proposed a novel algorithm …

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

JG Scott, A Berglund, MJ Schell, I Mihaylov… - The lancet …, 2017 - thelancet.com
Background Despite its common use in cancer treatment, radiotherapy has not yet entered
the era of precision medicine, and there have been no approaches to adjust dose based on …

Validation of a radiosensitivity molecular signature in breast cancer

SA Eschrich, WJ Fulp, Y Pawitan, JA Foekens… - Clinical Cancer …, 2012 - AACR
Purpose: Previously, we developed a radiosensitivity molecular signature [radiosensitivity
index (RSI)] that was clinically validated in 3 independent datasets (rectal, esophageal, and …

Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy

KA Ahmed, JJ Caudell, G El-Haddad… - International Journal of …, 2016 - Elsevier
Purpose/Objectives Evidence from the management of oligometastases with stereotactic
body radiation therapy (SBRT) reveals differences in outcomes based on primary histology …

Decision support systems for personalized and participative radiation oncology

P Lambin, J Zindler, BGL Vanneste… - Advanced drug delivery …, 2017 - Elsevier
A paradigm shift from current population based medicine to personalized and participative
medicine is underway. This transition is being supported by the development of clinical …

[HTML][HTML] Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system

RA Bekker, S Kim, S Pilon-Thomas, H Enderling - Neoplasia, 2022 - Elsevier
Radiotherapy is a primary therapeutic modality widely utilized with curative intent.
Traditionally tumor response was hypothesized to be due to high levels of cell death …

[HTML][HTML] The radiosensitivity index predicts for overall survival in glioblastoma

KA Ahmed, P Chinnaiyan, WJ Fulp, S Eschrich… - Oncotarget, 2015 - ncbi.nlm.nih.gov
We have previously developed a multigene expression model of tumor radiosensitivity (RSI)
with clinical validation in multiple cohorts and disease sites. We hypothesized RSI would …